Thank you, Madam Chair, and I thank the witnesses.
I think it was you, Mr. Fay, who mentioned the TRIPS segment of the WTO.
I was wondering if you could expand on that in terms of IP rights around vaccinations—especially as, obviously, we're dealing with a great deal of vaccination talk now—and the temporary waiver that Canada hasn't signed on to. What is the impact of that?